PFE peer analysis
Pfizer (PFE) against its competitors: price, today's move, 1-year return and market value side by side.
PFE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABBV AbbVie | $288.89 | -2.03% | 26.74% | $521.11B |
| AZN AstraZeneca | $186.20 | -0.24% | 13.13% | $289.48B |
| BMY Bristol-Myers Squibb | $62.60 | 0.19% | 37.20% | $127.71B |
| GILD Gilead | $169.29 | -0.81% | 42.97% | $211.70B |
| GSK GSK | $48.99 | -1.05% | 4.35% | $99.19B |
| JNJ Johnson & Johnson | $268.89 | -1.58% | 42.12% | $657.68B |
| LLY Eli Lilly | $1,405.43 | -0.85% | 66.74% | $1.26T |
| MRK Merck | $148.52 | -0.67% | 72.16% | $368.89B |
| NVS Novartis | $160.84 | 0.03% | 31.10% | $303.67B |
| SNY Sanofi | $45.23 | 2.01% | -11.18% | $106.24B |
| PFE Pfizer | $30.49 | -0.10% | 25.11% | $173.95B |
- PFE's peers: ABBV (AbbVie), AZN (AstraZeneca), BMY (Bristol-Myers Squibb), GILD (Gilead), GSK (GSK), JNJ (Johnson & Johnson), LLY (Eli Lilly), MRK (Merck).
Updated 2026-11-02 17:14 UTC